Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Non-Current Assets (2018 - 2025)

Avai Bio's Non-Current Assets history spans 7 years, with the latest figure at $205932.0 for Q1 2024.

  • On a quarterly basis, Non-Current Assets rose 53.81% to $205932.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $996382.0, a 78.41% increase, with the full-year FY2024 number at $205932.0, up 53.81% from a year prior.
  • Non-Current Assets hit $205932.0 in Q1 2024 for Avai Bio, down from $253199.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for AVAI hit a ceiling of $273784.0 in Q2 2023 and a floor of $26259.0 in Q4 2020.
  • Historically, Non-Current Assets has averaged $143428.5 across 5 years, with a median of $139622.5 in 2022.
  • Biggest five-year swings in Non-Current Assets: surged 8105.94% in 2020 and later plummeted 36.83% in 2022.
  • Tracing AVAI's Non-Current Assets over 5 years: stood at $26259.0 in 2020, then soared by 646.32% to $195976.0 in 2021, then fell by 29.73% to $137710.0 in 2022, then soared by 83.86% to $253199.0 in 2023, then decreased by 18.67% to $205932.0 in 2024.
  • Business Quant data shows Non-Current Assets for AVAI at $205932.0 in Q1 2024, $253199.0 in Q4 2023, and $263467.0 in Q3 2023.